Investigating the natural course and treatment of vascular dementia and Alzheimer's disease. Parallel study populations in two randomized, placebo-controlled trials.
Kittner
B
B
European/Canadian Propentofylline Study Group, Aventis Pharmaceuticals, Bridgewater, New Jersey 08807, USA.
De Deyn
P P
PP
Erkinjuntti
T
T
D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy* / Q000503:physiopathology* / Q000523:psychology; D003071:Cognition; D015140:Dementia, Vascular / Q000188:drug therapy* / Q000503:physiopathology* / Q000523:psychology; D018450:Disease Progression; D005260:Female; D006801:Humans; D008297:Male; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D018579:Patient Selection; D010919:Placebos; D011581:Psychological Tests; D014970:Xanthines / Q000627:therapeutic use*
D018696:Neuroprotective Agents; D010919:Placebos; D014970:Xanthines; C032114:propentofylline